Back

Evaluation of remote phenotyping in individuals with 3q29 deletion syndrome and development of a transdiagnostic screening protocol that can be deployed remotely

Pollak, R. M.; Harner, M. K.; Bishop, D. V.; Purcell, J.; Irving, T.; Sefik, E.; Klaiman, C.; Saulnier, C. A.; Pulver, S.; Walker, E.; Cubells, J.; Murphy, M. M.; Mulle, J. G.

2025-10-02 psychiatry and clinical psychology
10.1101/2025.10.01.25336891 medRxiv
Show abstract

Advances in genomics have resulted in a rapid expansion of the number of known rare genetic disorders (RGDs). However, the low frequency of RGDs presents a challenge for accurately describing the phenotypic spectrum of a given disorder. Remote phenotyping strategies are uniquely poised to address this knowledge gap. Here, we have piloted remote evaluation of cognitive ability and psychosis spectrum symptoms in 21 individuals with 3q29 deletion syndrome (3q29del) (57% male, mean age=14.3{+/-}8.6 years), a hallmark RGD. We find that remote cognitive assessment using the Penn Computerized Neurocognitive Battery and the Peabody Picture Vocabulary Test accurately captured full scale (r=0.710, p=0.001) and verbal IQ (r=0.637, p=0.003), respectively, as compared to in-person assessment with gold-standard instruments. Psychosis spectrum symptoms measured using the Structured Interview for Prodromal Syndromes were significantly correlated between in-person and remote evaluations (total score r=0.753, p=0.003; positive domain score r=0.806, p=0.0009). Based on the successful pilot of remote phenotyping in 3q29del, we designed a protocol for remote phenotyping of individuals with 3q29del. The phenotyping battery is comprised of caregiver-report and direct assessments to capture the spectrum of neurodevelopmental, neuropsychiatric, and medical features associated with the 3q29 deletion. While we designed the battery based on specific areas of concern for 3q29del, the high degree of phenotypic overlap between 3q29del and other RGDs renders this protocol amenable for implementation across a variety of RGDs, facilitating deeper understanding of the phenotypic spectrum and cross-disorder comparison. Ultimately, we hope that the increased utilization of remote phenotyping strategies will help to expand our understanding of RGDs at large, which will lead to improved clinical management strategies and better long-term outcomes for affected individuals and their families.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
22 papers in training set
Top 0.1%
10.2%
2
Disease Models & Mechanisms
119 papers in training set
Top 0.1%
9.3%
3
Genetics in Medicine
69 papers in training set
Top 0.3%
7.3%
4
Human Genetics and Genomics Advances
70 papers in training set
Top 0.1%
4.9%
5
Genome Medicine
154 papers in training set
Top 1%
4.9%
6
Translational Psychiatry
219 papers in training set
Top 1%
4.4%
7
Journal of Medical Genetics
28 papers in training set
Top 0.1%
4.2%
8
European Journal of Human Genetics
49 papers in training set
Top 0.2%
4.0%
9
Scientific Reports
3102 papers in training set
Top 35%
3.6%
50% of probability mass above
10
npj Genomic Medicine
33 papers in training set
Top 0.2%
3.1%
11
Neurology Genetics
14 papers in training set
Top 0.1%
3.1%
12
PLOS ONE
4510 papers in training set
Top 42%
3.1%
13
American Journal of Psychiatry
20 papers in training set
Top 0.1%
2.1%
14
Human Molecular Genetics
130 papers in training set
Top 1%
1.9%
15
Frontiers in Psychiatry
83 papers in training set
Top 2%
1.9%
16
Psychiatry Research
35 papers in training set
Top 0.8%
1.9%
17
Schizophrenia Bulletin
29 papers in training set
Top 0.4%
1.7%
18
JAMA Psychiatry
13 papers in training set
Top 0.3%
1.5%
19
Molecular Psychiatry
242 papers in training set
Top 2%
1.5%
20
Nature Medicine
117 papers in training set
Top 4%
1.0%
21
Biological Psychiatry
119 papers in training set
Top 2%
1.0%
22
BioData Mining
15 papers in training set
Top 0.7%
0.8%
23
The American Journal of Human Genetics
206 papers in training set
Top 3%
0.8%
24
Acta Psychiatrica Scandinavica
10 papers in training set
Top 0.3%
0.8%
25
Journal of Neurodevelopmental Disorders
15 papers in training set
Top 0.4%
0.8%
26
Molecular Autism
29 papers in training set
Top 0.4%
0.8%
27
Journal of Personalized Medicine
28 papers in training set
Top 1%
0.8%
28
NeuroImage: Clinical
132 papers in training set
Top 4%
0.8%
29
Frontiers in Neurology
91 papers in training set
Top 5%
0.7%
30
Schizophrenia
19 papers in training set
Top 0.4%
0.7%